The Food and Drug Administration (FDA) is asking recovered COVID-19 patients to donate plasma to assist in the development of blood-related therapies.
The agency said those who have recovered from COVID-19 could produce "an immediate impact" by donating plasma to help others who contract the virus.
"In fact, one donation has the potential to help up to four patients. Convalescent plasma can also be used to manufacture a biological product called hyperimmune globulin, which can similarly be used to treat patients with COVID-19," the news release states. "We encourage individuals to consider donating and hope this information will serve as a helpful resource to facilitate this important act of kindness," the FDA said.
However, the FDA will only consider patients who have fully recovered from the CCP virus for at least two weeks. They can contact their local blood or plasma donation center, the agency said.
"It is important that we evaluate this potential therapy in the context of clinical trials, through expanded access, as well as facilitate emergency access for individual patients, as appropriate," according to the release.